iSpecimen Inc. has announced it entered into a Securities Purchase Agreement with certain accredited investors for a private placement of 6,875 shares of its newly-designated Series C Convertible Non-Voting Preferred Stock. The shares, with a stated value of $1,000 each, were sold at a purchase price of $800 per share and are convertible into common stock at a price equal to 85% of the closing price on the trading day prior to conversion, subject to a floor price of $0.0681 per share. The sale was conducted as an unregistered offering under Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D, with E.F. Hutton & Co. serving as exclusive placement agent.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. iSpecimen Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-000496), on January 02, 2026, and is solely responsible for the information contained therein.